Fluticasone Furoate and Vilanterol

Prasco Laboratories🇺🇸 United States

FDA Page

Effective Date: Nov 21, 2024
Approval ID: 3a761487-c300-451a-8537-3196c00c11b5
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Fluticasone Furoate/Vilanterol ELLIPTA safely and effectively. See full prescribing information for Fluticasone Furoate/Vilanterol ELLIPTA. Fluticasone Furoate/Vilanterol ELLIPTA inhalation powder, for oral inhalation useInitial U.S. Approval: 2013

Quick Stats

Total Products2

Labelers2

Label Sections35

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.